Journal Article
Published 2021
Potential of Malawi’s medicinal plants in Covid-19 disease management: A review
Indexed 2 years ago
•
1287 Views
Dr. David Tembo
Co-author
Physics & Biochemical Sciences
8 total publications
David Tryson Tembo is a Senior Lecturer at Malawi University of Business and Applied Sciences (MUBAS). He is a holder of a Doctor of Philosophy, PhD (Food Science, University of Leeds, United Kingdom, 2017), Master of Science, MSc (Applied Chemistry,...
Primary Author
Ibrahim Chikowe
Co-Authors
Andrew G. Mtewa, Dallas Smith, Dr. David Tembo, Edna Ibrahim, Bonface Mwamatope, Justin Nkhungulu, Peter Kumpalume, Alfred Maroyi
Abstract
The Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has triggered an international pandemic that has led to significant public health problems. To date, limited evidence exists to suggest that drugs are effective against the disease. As possible treatments are being investigated, herbal medicines have shown potential for producing novel antiviral agents for the COVID-19 disease.
Aim: This review explored the potential of Malawi’s traditional medicinal plants for the management of COVID-19.
Methods: The authors searched on PubMed and Google scholar for medicinal plants that are used in Malawi and published in openly available peer reviewed journals. Plants linked with antiviral treatment, anti-COVID-19 activity or COVID-19 symptoms management were targeted. These included activity against pneumonia, inflammation, cough, difficulty in breathing, pain/aches, fever, diarrhea, rheumatism, fatigue, asthma, immunocompromised and cardiovascular diseases.
Results: 11 studies were found with 306 plant species. 127 plant species had at least one COVID-19 related pharmacological activity. Of these plant species, the number of herbal entities used for each indication was: pain/aches (87), fever (2), pneumonia (9), breathing/asthma problems (5), coughing (11), diarrhea (1), immunosuppression (8), blood issues (10), fatigue (2), heart problems (11), inflammation (8), rheumatism (10) and viral diseases (12). Thirty (30) species were used for more than one disease and Azedarach indica topped the list (6 of the 13 COVID-19 related diseases). The majority of the species had phytochemicals known to have antiviral activity or mechanisms of actions linked to COVID-19 and consequent diseases’ treatment pathways.
Conclusion: Medicinal plants are a promising source of compounds that can be used for drug development of COVID-19 related diseases. This review highlights potential targets for the World Health Organization and other research entities to explore in order to assist in controlling the pandemic.
Aim: This review explored the potential of Malawi’s traditional medicinal plants for the management of COVID-19.
Methods: The authors searched on PubMed and Google scholar for medicinal plants that are used in Malawi and published in openly available peer reviewed journals. Plants linked with antiviral treatment, anti-COVID-19 activity or COVID-19 symptoms management were targeted. These included activity against pneumonia, inflammation, cough, difficulty in breathing, pain/aches, fever, diarrhea, rheumatism, fatigue, asthma, immunocompromised and cardiovascular diseases.
Results: 11 studies were found with 306 plant species. 127 plant species had at least one COVID-19 related pharmacological activity. Of these plant species, the number of herbal entities used for each indication was: pain/aches (87), fever (2), pneumonia (9), breathing/asthma problems (5), coughing (11), diarrhea (1), immunosuppression (8), blood issues (10), fatigue (2), heart problems (11), inflammation (8), rheumatism (10) and viral diseases (12). Thirty (30) species were used for more than one disease and Azedarach indica topped the list (6 of the 13 COVID-19 related diseases). The majority of the species had phytochemicals known to have antiviral activity or mechanisms of actions linked to COVID-19 and consequent diseases’ treatment pathways.
Conclusion: Medicinal plants are a promising source of compounds that can be used for drug development of COVID-19 related diseases. This review highlights potential targets for the World Health Organization and other research entities to explore in order to assist in controlling the pandemic.
Year of Publication
2021
External Digital Object URL
Access Publisher / External Source
Journal Name
Malawi Medical Jounal
Volume
33
Issue
2
Page Numbers
1-23
Supporting Files & Downloads
Related Publications & Research
Similar Research FieldsFeatured Top Researchers
“Academic success depends on research and publications.” — Philip Zimbardo
Dr. Kondwani Chidziwisano
Public Health and Environmental Sciences
Contributions
61 Works
Dr. Robert Suya
Physical Planning and Land Surveying
Contributions
39 Works
Prof. Harold Wilson Tumwitike Mapoma
Physics & Biochemical Sciences
Contributions
31 Works
Assoc. Prof. Moses V. M. Chamba
Physics & Biochemical Sciences
Contributions
30 Works